Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
Dicerna Pharmaceuticals Inc
DRNA·253031108·US·Common Stock
DRNA (Dicerna Pharmaceuticals Inc) is held by 0 institutional investors as of Q4 2021.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold DRNA.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $226,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $69,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $482,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $477,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $6.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $26.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.5M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $68,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $219,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $389,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $152.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $11,000 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $15.4M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $127,000 | 0.0% | — | 0 |
Showing 1-20 of 88
1 / 5
DRNADicerna Pharmaceuticals IncContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer